Disease Info Card

Hepatorenal Syndrome

Information about Hepatorenal Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hepatorenal Syndrome

Most recent studies have shown that Hepatorenal Syndrome shares some biological mechanisms with acute-kidney-injury, bacterial-peritonitis, encephalopathies, gastrointestinal-hemorrhage, hemorrhage, hepatic-encephalopathy, hepatitis, hypertension-portal, hypertensive-disease, kidney-diseases, kidney-failure, kidney-failure-acute, kidney-failure-chronic, liver-cirrhosis, liver-diseases, liver-failure, liver-failure-acute, pathologic-vasoconstriction, peritonitis, primary-bacterial-peritonitis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hepatorenal Syndrome, and have been seen in publications frequently: Aldosterone Secretion, Angiogenesis, Coagulation, Diuresis, Excretion, Glomerular Filtration, Hemostasis, Immune Response, Inflammatory Response, Natriuresis, Pathogenesis, Platelet Aggregation, Reflex, Regeneration, Renal Sodium Excretion, Secretion, Transport, Tubuloglomerular Feedback, Vasoconstriction, Vasodilation

Quite a number of genes have been found to play important roles in Hepatorenal Syndrome, such as AGT, ALB, ATN1, AVP, BCHE, CDKN2A, EDN1, F2, GNL3, HGS, LTA, RAPGEF5, REN, SGSM3, SLA2, SLC17A5, SRSF5, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.